CHAMP1 disorder is associated with a complex neurobehavioral phenotype including autism, ADHD, repetitive behaviors and sensory symptoms.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
17 08 2022
Historique:
received: 19 11 2021
revised: 17 12 2021
accepted: 02 01 2022
pubmed: 11 3 2022
medline: 25 8 2022
entrez: 10 3 2022
Statut: ppublish

Résumé

CHAMP1-related neurodevelopmental disorder, or CHAMP1 disorder, is a recently described genetic syndrome associated with developmental delay, intellectual disability, behavioral symptoms, medical comorbidities, and dysmorphic features. To date, literature has focused on medical review and dysmorphology but has yet to prospectively assess neurobehavioral core domains such as autism, or behavioral, language, cognitive, and sensory features. Here, we present deep phenotyping results for 11 individuals with CHAMP1 disorder, based on approximately 12 hours of remote clinician-administered assessments and standardized caregiver questionnaires. Diagnoses of autism spectrum disorder were given to 33% of participants; repetitive behaviors and sensory-seeking symptoms were prominent in this cohort. In addition, 60% of participants met the criteria for attention-deficit/hyperactivity disorder (ADHD). High rates of ADHD and relatively low rates of treatment suggest potential areas for intervention. This study represents the first prospective phenotyping analysis of individuals with CHAMP1 disorder. The utility of specific measures as clinical endpoints, as well as benefits and limitations of remote phenotyping, are described.

Identifiants

pubmed: 35271727
pii: 6528266
doi: 10.1093/hmg/ddac018
pmc: PMC9396938
doi:

Substances chimiques

CHAMP1 protein, human 0
Chromosomal Proteins, Non-Histone 0
Phosphoproteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2582-2594

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH111661
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Nature. 2012 Apr 04;485(7397):246-50
pubmed: 22495309
Front Pediatr. 2021 Feb 19;9:526779
pubmed: 33681094
J Autism Dev Disord. 1980 Mar;10(1):91-103
pubmed: 6927682
Hum Mutat. 2016 Apr;37(4):354-8
pubmed: 26751395
JAMA. 2014 Nov 12;312(18):1870-9
pubmed: 25326635
Am J Occup Ther. 1997 Jan;51(1):25-34
pubmed: 8978860
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
N Engl J Med. 2012 Nov 15;367(20):1921-9
pubmed: 23033978
J Autism Dev Disord. 2007 May;37(5):855-66
pubmed: 17048092
Nat Genet. 2007 Jan;39(1):25-7
pubmed: 17173049
N Engl J Med. 2012 Feb 23;366(8):733-43
pubmed: 22356326
Cell. 2020 Feb 6;180(3):568-584.e23
pubmed: 31981491
Phys Occup Ther Pediatr. 2009;29(2):182-202
pubmed: 19401931
Nature. 2012 Apr 04;485(7397):242-5
pubmed: 22495311
Genet Med. 2019 Nov;21(11):2413-2421
pubmed: 31182824
Genes (Basel). 2021 Feb 27;12(3):
pubmed: 33673501
Pharmacol Rep. 2014 Oct;66(5):830-5
pubmed: 25149987
Am J Hum Genet. 2015 Sep 3;97(3):493-500
pubmed: 26340335
Genet Med. 2010 Nov;12(11):742-5
pubmed: 20962661
Autism Res. 2017 Jun;10(6):1133-1140
pubmed: 28296264
Dev Psychopathol. 2014 Feb;26(1):203-14
pubmed: 24274034
Cold Spring Harb Mol Case Stud. 2021 Aug 2;7(4):
pubmed: 34021018
Hum Genomics. 2019 Jul 9;13(1):31
pubmed: 31288856
Nature. 2015 Mar 12;519(7542):223-8
pubmed: 25533962
EMBO J. 2011 Jan 5;30(1):130-44
pubmed: 21063390
Nature. 2014 Nov 13;515(7526):209-15
pubmed: 25363760
Mol Autism. 2021 Sep 29;12(1):61
pubmed: 34588003
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Oct;22(10):1131-1134
pubmed: 33059813
Nat Genet. 2003 May;34(1):27-9
pubmed: 12669065
Mol Autism. 2021 Oct 6;12(1):65
pubmed: 34615535
Cold Spring Harb Mol Case Stud. 2016 Jan;2(1):a000661
pubmed: 27148580
Transl Psychiatry. 2017 Feb 21;7(2):e1043
pubmed: 28221363
Genet Med. 2013 May;15(5):399-407
pubmed: 23519317

Auteurs

Tess Levy (T)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Bonnie Lerman (B)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Danielle Halpern (D)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Yitzchak Frank (Y)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Christina Layton (C)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Jessica Zweifach (J)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Paige M Siper (PM)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Joseph D Buxbaum (JD)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Alexander Kolevzon (A)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH